Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Matinas Biopharma Holdings, Inc. (MTNB) had Weighted-Average Shares Outstanding (Diluted) of 4.87M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-24.25M |
|
-- |
|
-- |
|
$24.59M |
|
$-24.59M |
|
$0.26M |
|
$-24.33M |
|
$-24.33M |
|
$-24.25M |
|
$-24.25M |
|
$-24.25M |
|
$-24.25M |
|
$-24.59M |
|
$-23.64M |
|
4.87M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
4.87M |
$-4.98 |
|
$-4.98 |
|
| Balance Sheet Financials | |
$8.03M |
|
$0.47M |
|
$4.62M |
|
$12.64M |
|
$2.67M |
|
$0.01M |
|
$2.38M |
|
$5.05M |
|
$7.59M |
|
$7.59M |
|
$7.59M |
|
5.09M |
|
| Cash Flow Statement Financials | |
$-15.88M |
|
$9.21M |
|
$9.17M |
|
$5.04M |
|
$7.53M |
|
$2.50M |
|
$3.19M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.01 |
|
-- |
|
-- |
|
0.00 |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-15.88M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-319.51% |
|
-319.51% |
|
-191.84% |
|
-319.01% |
|
$1.49 |
|
$-3.26 |
|
$-3.26 |
|